KIHARA JAMES 1816160 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-17 | 2023-05-17 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 11894.0 | 69.59 | 0.73 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 17091.0
|
162.63 (ACAD) |
| 2023-05-19 | 2023-05-17 | 2023-05-17 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 5947.0 | 34.8 | 0.37 | 22.5 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 11144.0 | 162.63 (ACAD) |
| 2023-06-16 | 2023-06-15 | 2023-06-15 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 2000.0 | 17.95 | 0.12 | 24.15 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 9144.0 | 162.63 (ACAD) |
| 2023-09-19 | 2023-09-15 | 2023-09-15 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 2000.0 | 15.65 | 0.12 | 25.88 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 10778.0 | 163.73 (ACAD) |
| 2023-11-21 | 2023-11-17 | 2023-11-17 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 3964.0 | 26.41 | 0.24 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 15010.0
|
164.18 (ACAD) |
| 2023-11-21 | 2023-11-17 | 2023-11-20 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 1985.0 | 13.22 | 0.12 | 22.64 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 13025.0 | 164.18 (ACAD) |
| 2023-12-15 | 2023-12-15 | 2023-12-15 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 2000.0 | 15.36 | 0.12 | 28.3 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 11025.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-26 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 474.0 | 3.99 | 0.03 | 24.67 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 11391.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 840.0 | 7.08 | 0.05 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 11865.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-08 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 1790.0 | 12.02 | 0.11 | 17.87 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 13100.0
|
164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-05 to 2024-04-07 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 3499.0 | 23.5 | 0.21 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 14890.0
|
164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-02 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 1326.0 | 8.45 | 0.08 | 16.94 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 14370.0 | 164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 2596.0 | 16.54 | 0.16 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 15696.0 | 164.18 (ACAD) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-17 | 2023-05-17 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 11894.0 | 54.54 | 0.73 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 9913.0
|
162.63 (ACAD) |
| 2023-11-21 | 2023-11-17 | 2023-11-17 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 3964.0 | 33.32 | 0.24 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 7931.0
|
164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 840.0 | 50.0 | 0.05 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 840.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 13964.0 | 100.0 | 0.85 | 17.84 | Direct | Stock Options (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 13964.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | acq | 8568.0 | 100.0 | 0.52 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 8568.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-05 to 2024-04-07 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 3499.0 | 100.0 | 0.21 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0
|
164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Kihara James | PRINCIPAL ACCOUNTING OFFICER | dsp | 2596.0 | 25.0 | 0.16 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 7788.0 | 164.18 (ACAD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)